An 83-year-old female had asymptomatic SARS-CoV-2 infection while taking ruxolitinib. She remained RT-PCR positive for viral RNA for >120 days, and Pegylated interferon for 4 weeks led to viral RNA clearance. The observations support combination therapy of ruxolitinib + interferon for COVID-19.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077319 | PMC |
| http://dx.doi.org/10.1002/ccr3.3997 | DOI Listing |
Publication Analysis
Top Keywords
pegylated interferon
8
viral rna
8
response pegylated
4
interferon covid-19-positive
4
covid-19-positive elderly
4
elderly woman
4
woman primary
4
primary myelofibrosis
4
myelofibrosis treated
4
treated ruxolitinib
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!